{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:06:59Z","timestamp":1769602019246,"version":"3.49.0"},"reference-count":60,"publisher":"Consilium Medicum","issue":"7","license":[{"start":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Terapevticheskii arkhiv"],"abstract":"<jats:p>Aim of the issue was to compare clinical characteristics and treatment results of patients with follicular lymphoma (FL) with translocations involving loci of c-MYC\/8q24, BCL2\/18q21 and\/or BCL6\/3q27 genes and patients with high - grade B-cell lymphoma [High - grade B-cell lymphoma (HGBL), double - hit (DH)]. Materials and methods. Since 2004 to 2017 years in National Research Center for Hematology 12 patients with high - grade B-cell lymphoma double - hit (HGBL DH) and 6 FL patients with translocations involving c-MYC and BCL2 and\/or BCL6 had been treated. We performed a comparative analysis of clinical characterisctics in both groups. As primary endpoints was assessed frequency of complete remission (CR) or progressive disease (PD); as secondary endpoints - overall (OS) and event - free survival (EFS). Results. 5 patients with HGBL DH had c-MYC\/BCL6, 7 - c-MYC\/BCL2 rearrangements; 2 patients with FL had c-MYC\/BCL2, 3 - c-MYC\/BCL6, 1 - c-MYC\/BCL2\/BCL6 rearrangements. FL was represented by grade 3A in 2, grade 3B - in 4 cases, 3 of them had large - cell transformation. In HGBL DH and FL patients had no significant differences in clinical characteristics. The majority of patients had a widespread tumour, increased LDH activity, high frequency of extranodal and bone marrow involvement. Ki-67 expression level was lower in patients with FL (p<\/jats:p>","DOI":"10.26442\/00403660.2019.07.000070","type":"journal-article","created":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T22:18:01Z","timestamp":1564957081000},"page":"52-62","source":"Crossref","is-referenced-by-count":1,"title":["The role of translocations involving c-MYC\/8q24, BCL2\/18q21 and\/or BCL6\/3q27 genes in patients with follicular lymphoma. Retrospective analysis of single - centre data"],"prefix":"10.26442","volume":"91","author":[{"given":"A E","family":"Misyurina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S K","family":"Kravchenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A M","family":"Kovrigina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A U","family":"Magomedova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L V","family":"Plastinina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T N","family":"Obukhova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A V","family":"Misyurin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V A","family":"Misyurin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L A","family":"Grebenuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F E","family":"Babaeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E A","family":"Baryakh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A I","family":"Vorobiev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18344","published-online":{"date-parts":[[2019,7,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-09-297879"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.17650\/1726-9784-2016-15-4-18-24"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/PAP.0b013e3182a289f2"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-212191"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11305"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11263"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.344"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2012.017"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Snuderl M, Kolman O.K, Chen Y.B, Hsu J.J, Ackerman A.M, Dal Cin P, Ferry J.A, Harris N.L, Hasserjian R.P, Zukerberg L.R, Abramson J.S, Hochberg E.P, Lee H, Lee A.I, Toomey C.E, Sohani A.R. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. American J Surgical Pathology. 2010;34:327-40. doi: 10.1097\/ PAS.0b013e3181cd3aeb","DOI":"10.1097\/PAS.0b013e3181cd3aeb"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.17116\/terarkh201587491-97"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Ji M, Jang S, Lee J.H, Seo E.J. Double - hit myeloma with IGH\/MYC and IGH\/CCND1 translocations. Ann Hematol. 2013;92(8):1129-31. doi: 10.1007\/ s00277-012-1668-y","DOI":"10.1007\/s00277-012-1668-y"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/01.MP.0000"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07152.x"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Mohamed A.N, Palutke M, Eisenberg L, Al-Katib A. Chromosomal analyses of 52 cases of follicular lymphoma with t(14;18), including blastic\/blastoid variant. Cancer Genetics and Cytogenetics. 2001;126:45-51.","DOI":"10.1016\/S0165-4608(00)00383-6"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.042531"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.hum"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-498329"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/genes"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.5.1558"},{"key":"ref20","unstructured":"\u0411\u0430\u0440\u044f\u0445 \u0415.\u0410., \u041c\u0438\u0441\u044e\u0440\u0438\u043d\u0430 \u0410.\u0415., \u041a\u043e\u0432\u0440\u0438\u0433\u0438\u043d\u0430 \u0410.\u041c., \u041e\u0431\u0443\u0445\u043e\u0432\u0430 \u0422.\u041d., \u041a\u0440\u0430\u0432\u0447\u0435\u043d\u043a\u043e \u0421.\u041a., \u041c\u0430\u0433\u043e\u043c\u0435\u0434\u043e\u0432\u0430 \u0410.\u0423., \u0417\u0438\u043d\u0433\u0435\u0440\u043c\u0430\u043d \u0411.\u0412., \u041c\u0438\u0441\u044e\u0440\u0438\u043d\u0430 \u0415.\u041d., \u041f\u043e\u0442\u0435\u0448\u043a\u0438\u043d\u0430 \u041d.\u0413., \u041b\u044b\u0441\u0435\u043d\u043a\u043e \u041c.\u0410., \u0412\u043e\u0440\u043e\u0431\u044c\u0435\u0432 \u0410.\u0418. \u041a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u043e\u0441\u043e\u0431\u0435\u043d\u043d\u043e\u0441\u0442\u0438 \u0438 \u0442\u0435\u0440\u0430\u043f\u0438\u044f double - hit \u0438 double - expressor \u043b\u0438\u043c\u0444\u043e\u043c. \u0421\u043e\u0432\u0440\u0435\u043c\u0435\u043d\u043d\u0430\u044f \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u044f. 2016;18(5):22-30."},{"key":"ref21","unstructured":"Swerdlow S.H, Campo E, Harris N.L, Jaffe E.S, Pileri S.A, Stein H, Thiele J, Vardiman J.W. Classification of Tumours of Haematopoietic and Lymphoid Tissues. WHO Classification of Tumours, Revised 4th Edition, Volume 2. Lyon: IARC Press, 2017."},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Momose S, Wei\u00dfbach S, Pischimarov J, Nedeva T, Bach E, Rudelius M, Geissinger E, Staiger A.M, Ott G, Rosenwald A. The diagnostic gray zone between Burkitt lymphoma and diffuse large B-cell lymphoma is also a gray zone of the mutational spectrum. Leukemia. 2015;29(8):1789-91. doi: 10.1038\/ leu.2015.34","DOI":"10.1038\/leu.2015.34"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2014.1.90"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-10-671362"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055351"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.147"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13276"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2008.005355"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12982"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-20"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2014.12.015"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2012.04301.x"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9473"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701836845"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Yano T, Jaffe E.S, Longo D.L, Raffeld M. MYC rearrangements in histologically progressed follicular lymphomas. Blood. 1992;80:758-67.","DOI":"10.1182\/blood.V80.3.758.bloodjournal803758"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.18282\/amor.v3.i3.169"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1080\/10428190310001625674"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1043\/1543-2165(2004)128<210:FLWABT>"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/mod"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-691345"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2013.12.027"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Lo Coco F, Gaidano G, Louie D.C, Offit K, Chaganti R.S, Dalla-Favera R. P53 mutations are associated with histologic transformation of follicular lymphoma. Blood. 1993;82(8):2289-95.","DOI":"10.1182\/blood.V82.8.2289.bloodjournal8282289"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Sander C.A, Yano T, Clark H.M, Harris C, Longo D.L, Jaffe E.S, Raffeld M. P53 mutation is associated with progression in follicular lymphomas. Blood. 1993; 82(7):1994-2004.","DOI":"10.1182\/blood.V82.7.1994.1994"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Au W.Y, Horsman D.E, Gascoyne R.D, Viswanatha D.S, Klasa R.J, Connors J.M. The spectrum of lymphoma with 8q24 aberrations: a clinical, pathological and cytogenetic study of 87 consecutive cases. Leuk Lymphoma. 2004;45(3):519-28.","DOI":"10.1080\/10428190310001593120"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.132253599"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-2175"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404696"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Elenitoba-Johnson K.S, Gascoyne R.D, Lim M.S, Chhanabai M, Jaffe E.S, Raffeld M. Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma. Blood. 1998;91(12):4677-85.","DOI":"10.1182\/blood.V91.12.4677"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Pinyol M, Cobo F, Bea S, Jares P, Nayach I, Fernandez P.L, Montserrat E, Cardesa A, Campo E. p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin\u2019s lymphomas. Blood. 1998;91(8):2977-84.","DOI":"10.1182\/blood.V91.8.2977.2977_2977_2984"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-011-1162-y"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Natkunam Y, Warnke R.A, Zehnder J.L, Jones C.D, Milatovich-Cherry A, Cornbleet P.J. Blastic\/Blastoid Transformation of Follicular Lymphoma: Immunohistologic and Molecular Analyses of Five Cases. Amer J Surgical Pathology. 2000;24(4):525-34.","DOI":"10.1097\/00000478-200004000-00006"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.17116\/terarkh201688762-71"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Yunis J.J, Soreng A.L. Constitutive fragile sites and cancer. Science. 1984;226:1199-204.","DOI":"10.1126\/science.6239375"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Thangavelu M, Olopade O, Beckman E, Vardiman J.W, Larson R.A, McKeithan T.W, Le Beau M.M, Rowley J.D. Clinical, morphologic, and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18)(q32;q21) and t(8;14)(q24; q32) or t(8;22)(q24;q11). Genes Chromosomes Cancer. 1990;2:147-58.","DOI":"10.1002\/gcc.2870020211"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Offit K, Jhanwar S.C, Ladanyi M, Filippa D.A, Chaganti R.S. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin\u2019s lymphoma: correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment. Genes Chromosomes Cancer. 1991;3:189-201.","DOI":"10.1002\/gcc.2870030304"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Karsan A, Gascoyne R.D, Coupland R.W, Shepherd J.D, Phillips G.L, Horsman D.E. Combination of t(14;18) and a Burkitt\u2019s type translocation in B-cell malignancies. Leuk Lymphoma. 1993;10;433-41.","DOI":"10.3109\/10428199309148200"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Stamatoullas A, Buchonnet G, Lepretre S, Lenain P, Lenormand B, Duval C, Callat M.P, Gaulard P, Bastard C, Tilly H. De novo acute B-cell leukemia\/lymphoma with t(14;18). Leukemia. 2000;14:1960-6.","DOI":"10.1038\/sj.leu.2401910"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28642"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.281"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"link":[{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/33600\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/33600\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T21:40:36Z","timestamp":1634161236000},"score":1,"resource":{"primary":{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/view\/33600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,15]]},"references-count":60,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7,15]]}},"URL":"https:\/\/doi.org\/10.26442\/00403660.2019.07.000070","relation":{},"ISSN":["2309-5342","0040-3660"],"issn-type":[{"value":"2309-5342","type":"electronic"},{"value":"0040-3660","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7,15]]}}}